Carolinas HealthCare System

Research and Clinical Trials

Title   A Multicenter Study for the Validation of ALS Biomarkers
Brief Description   The primary objective is to identify factors that contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS). Development of disease biomarkers and diagnostic laboratory tests would facilitate earlier treatment intervention, help monitor treatment efficacy; and, ultimately, lead to the identification of targets that could be used in therapy development. Specific aim 2 is to assess how biomarkers discovered in aim 1 change with disease course. Blood samples will be collected longit
Who may be Eligible   Male and females over the age of 18 with a diagnosis of ALS.
Specialty/Disorder   ALS - Amyotrophic Lateral Sclerosis
IRBĀ Number   06-10-03A
PrincipalĀ Investigator   Brooks, Benjamin
For More Information, Contact   Jaime  L.  Shue , RN
Phone:  (704) 446-6253  Fax:  (704) 446-1915 
Email:  jamie.shue@carolinashealthcare.org
Address:  1010 Edgehill Road North Charlotte, NC 28207
About Carolinas HealthCare System
Who We Are
Leadership
Community Benefit
Corporate Financial Information
Diversity and Inclusion
Annual Report
Foundation
Patient Links
Pay Your Bill
Hospital Pre-Registration
Patient Rights
Privacy Policy
Financial Assistance
Quality & Value Reports
Insurance
Careers
Join Carolinas HealthCare System
Physician Careers

For Employees
Carolinas Connect
Connect with Us
Watch Carolinas HealthCare on YoutubeFollow Carolinas HealthCare on TwitterLike Carolinas HealthCare on FacebookContact Carolinas HealthCareJoin Carolinas HealthCare on LinkedInGo to our mobile website.